In 2005, Superdrol was rereleased as an over the counter designer steroid. It was sold in many supplement stores without restriction. This was pulled off thanks to a “grey area” in the 1990 Anabolic Steroid Control Act and 2004 revision. The law is, in part, drug-specific and Superdrol was not declared a Schedule III class anabolic steroid in that act because it was not commercially available at the time the act, and its subsequent revision, were signed into law. Superdrol was therefore being sold as an over-the-counter dietary supplement.
Users on an oral steroid cycle may experience a sudden increase in body weight and muscular development, insomnia, irritability, aggressive combative behavior, puffy face, severe acne, bad breath, a yellowing of the eyes and skin, premature hair loss, hyperactivity, and exaggerated mood swings that include uncontrollable outbursts of anger. Males may also experience testicular shrinkage and can develop female breast tissue on the pectoral muscles. Females may also experience a deeper voice and decreased breast size. Continued use can result in life-threatening situations involving the liver, cardiovascular system, and brain.